PatientsVille.com Logo

PatientsVille

Ultram Side Effects

Common Ultram Side Effects


The most commonly reported Ultram side effects (click to view or check a box to report):

Convulsion (149)
Overdose (93)
Dizziness (58)
Nausea (56)
Vomiting (48)
Unresponsive To Stimuli (47)
Hypotension (44)
Somnolence (42)
Hypertension (37)
Loss Of Consciousness (35)
Headache (35)
Dyspnoea (33)
Tachycardia (33)
Pain (32)
Fall (29)
Confusional State (28)
Suicide Attempt (27)
Grand Mal Convulsion (25)
Insomnia (24)
Hyperhidrosis (23)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Ultram Side Effects Reported to FDA

The following Ultram reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Ultram on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Serotonin Syndrome, Adverse Event
This is a report of a 62-year-old female patient (weight: NA) from US, suffering from the following symptoms/conditions: facial pain,neuralgia, who was treated with Ultram (dosage: Maybe 2 Or 4 Times Per Day, start time: 201210), combined with:
  • Elavil
  • Tegretol
  • Percocet
  • Percocet
  • Botox
and developed a serious reaction and side effect(s). The consumer presented with:
  • Serotonin Syndrome
  • Adverse Event
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Ultram treatment in female patients, resulting in serotonin syndrome side effect. The patient was hospitalized.


This report suggests a potential Ultram side effect(s) that can have serious consequences. A 64-year-old female patient (weight: NA) from US was diagnosed with the following symptoms/conditions: NA and used Ultram (dosage: NA) starting Jul 17, 2013. Soon after starting Ultram the patient began experiencing various side effects, including:
    Drugs used concurrently: NA. Although Ultram demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as death, may still occur.

    Oesophageal Spasm
    This Oesophageal Spasm problem was reported by a physician from US. A 85-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: pain,tourette^s disorder,bipolar disorder,type 2 diabetes mellitus,parkinson^s disease. On NS this consumer started treatment with Ultram (dosage: NA). The following drugs were being taken at the same time:
    • Risperdal
    • Risperdal
    • Diabeta
    • Sinemet (Sinemet In Combination With Levodopa)
    • Requip
    • Prilosec
    • Lithobid
    When commencing Ultram, the patient experienced the following unwanted symptoms/side effects:
    • Oesophageal Spasm
    The patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as oesophageal spasm, may become evident only after a product is in use by the general population.

    Acromegaly, Empty Sella Syndrome, Sacroiliitis, Pulmonary Haemorrhage, Cholelithiasis, Pituitary Tumour Benign, Hand Deformity, Arthritis, Rotator Cuff Syndrome
    This is a report of a male patient (weight: NA) from CA. The patient developed the following symptoms/conditions: NA and was treated with Ultram (dosage: 3 Times A Day) starting NS. Concurrently used drugs:
    • Gabapentin (3 Times A Day)
    • Sandostatin (Month)
    • Sandostatin (Month)
    • Sandostatin (Every 3 Weeks)
    • Sandostatin (Monthly)
    • Celebrex
    • Proscar
    Soon after that, the consumer experienced the following side effects:
    • Acromegaly
    • Empty Sella Syndrome
    • Sacroiliitis
    • Pulmonary Haemorrhage
    • Cholelithiasis
    • Pituitary Tumour Benign
    • Hand Deformity
    • Arthritis
    • Rotator Cuff Syndrome
    This opens a possibility that Ultram treatment could cause the above reactions, including acromegaly, and some male subjects may be more susceptible.


    Spinal Fusion Surgery, Back Disorder, Pain, Product Packaging Quantity Issue
    A male patient (weight: NA) from US with the following symptoms/conditions: pain started Ultram treatment (dosage: NA) on 2004. Soon after starting Ultram treatment, the subject experienced various side effects, including:
    • Spinal Fusion Surgery
    • Back Disorder
    • Pain
    • Product Packaging Quantity Issue
    Concurrently used drugs:
    • Nucynta
    • Duragesic
    • Duragesic
    The patient was hospitalized. This finding indicates that some male patients could be more vulnerable to Ultram.

    Intentional Self-injury, Intentional Overdose, Confusional State, Feeling Abnormal
    A 22-year-old male patient from US (weight: NA) experienced symptoms, such as: NA and was treated with Ultram(dosage: Excess Of 1000mg). The treatment was initiated on NS. After that a consumer reported the following side effect(s):
    • Intentional Self-injury
    • Intentional Overdose
    • Confusional State
    • Feeling Abnormal
    Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Ultram efficacy: NA.

    Carpal Tunnel Syndrome, Vision Blurred, Feeling Abnormal
    In this report, Ultram was administered for the following condition: breakthrough pain,sleep disorder,neuropathy peripheral.A male consumer from US (weight: NA) started Ultram treatment (dosage: 50mg Two Tablets Every Four Or Six Hours) on 2009.Sometime after starting the treatment, the patient complained of the following side effect(s):
    • Carpal Tunnel Syndrome
    • Vision Blurred
    • Feeling Abnormal
    A possible interaction with other drugs could have contributed to this reaction:
    • Trazodone (Two 100mg Tablets At Night)
    • Fentanyl
    Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Ultram treatment could be related to the listed above side effect(s).

    Therapeutic Response Unexpected
    This is a report of the following Ultram side effect(s):
    • Therapeutic Response Unexpected
    A male patient from US (weight: NA) presented with the following condition: pain and received a treatment with Ultram (dosage: 3 Times In A Day) starting: NS.The following concurrently used drugs could have generated interactions: NA.This report suggests that a Ultram treatment could be associated with the listed above side effect(s).

    Loss Of Consciousness, Somnolence, Fall, Erythema, Headache, Acne, Rash
    This Ultram report was submitted by a 48-year-old female consumer from US (weight: NA). The patient was diagnosed with: NA and Ultram was administered (dosage: 1 To 2 Once In 6 Hours) starting: 201011. The consumer developed a set of symptoms:
    • Loss Of Consciousness
    • Somnolence
    • Fall
    • Erythema
    • Headache
    • Acne
    • Rash
    Other drugs used simultaneously:
    • Lyrica (3 Times A Day)
    • Neurontin
    • Valium
    • Vitamin A
    • Vitamin D
    • Vitamin B12
    • E Vitamin
    • Vitamin C
    Those unexpected symptoms could be linked to a Ultram treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.

    Angioedema, Anaesthesia Dolorosa, Weight Decreased, Pain, Blood Pressure Increased, Malaise, Temperature Intolerance, Eating Disorder, Emotional Disorder
    This is a report of a possible correlation between Ultram use and the following symptoms/side effect(s):
    • Angioedema
    • Anaesthesia Dolorosa
    • Weight Decreased
    • Pain
    • Blood Pressure Increased
    • Malaise
    • Temperature Intolerance
    • Eating Disorder
    • Emotional Disorder
    which could contribute to an assessment of Ultram risk profile.A 63-year-old female consumer from US (weight: NA) was suffering from pain,swelling and was treated with Ultram (dosage: NA) starting 2013.Other concurrent medications:
    • Amitriptyline
    • Lamictal
    • Tegretol
    • Oxycodone


    Overdose, Blood Creatinine Increased
    A 35-year-old male patient from US (weight: NA) presented with the following symptoms: pain and after a treatment with Ultram (dosage: NA) experienced the following side effect(s):
    • Overdose
    • Blood Creatinine Increased
    The treatment was started on NS. Ultram was used in combination with the following drugs: NA.The patient was hospitalized.This report could alert potential Ultram consumers.

    Nephrolithiasis, Eye Pruritus
    In this report, a 83-year-old male patient from US (weight: NA) was affected by a possible Ultram side effect.The patient was diagnosed with spinal column stenosis. After a treatment with Ultram (dosage: 4-6hours, start date: NS), the patient experienced the following side effect(s):
    • Nephrolithiasis
    • Eye Pruritus
    The following simultaneously used drugs could have led to this reaction: NA.The findings here stress that side effects should be taken into consideration when evaluating a Ultram treatment.

    Memory Impairment, Abnormal Loss Of Weight, Tremor, Malaise, Stress, Decreased Appetite
    This is a report of a 63-year-old female patient from US (weight: NA), who used Ultram (dosage: Every 6-8hours) for a treatment of arthritis. After starting a treatment on NS, the patient experienced the following side effect(s):
    • Memory Impairment
    • Abnormal Loss Of Weight
    • Tremor
    • Malaise
    • Stress
    • Decreased Appetite
    The following drugs could possibly have interacted with the Ultram treatment NA.The patient was hospitalized.Taken together, these observations suggest that a Ultram treatment could be related to side effect(s), such as Memory Impairment, Abnormal Loss Of Weight, Tremor, Malaise, Stress, Decreased Appetite.

    Inadequate Analgesia
    This inadequate analgesia side effect was reported by a consumer or non-health professional from US. A 55-year-old male patient (weight:NA) experienced the following symptoms/conditions: pain in extremity. The patient was prescribed Ultram (dosage: NA), which was started on May 18, 2013. Concurrently used drugs: NA. When starting to take Ultram the consumer reported the following symptoms:
    • Inadequate Analgesia
    These side effects may potentially be related to Ultram.

    Muscle Spasms, Convulsion, Vomiting, Tic, Nightmare, Anger
    This is a Ultram side effect report of a 49-year-old male patient (weight:NA) from US, suffering from the following symptoms/conditions: back pain, who was treated with Ultram (dosage:1 Every 4 Hrs, By Mouth, start time: 200806), combined with: NA., and developed a serious reaction and a muscle spasms side effect. The patient presented with:
    • Muscle Spasms
    • Convulsion
    • Vomiting
    • Tic
    • Nightmare
    • Anger
    which developed after the beginning of treatment. This side effect report can indicate a possible existence of increased vulnerability to Ultram treatment in male patients suffering from back pain, resulting in muscle spasms.

    Joint Range Of Motion Decreased, Pain In Extremity, Insomnia, Treatment Noncompliance
    This report suggests a potential Ultram joint range of motion decreased side effect(s) that can have serious consequences. A female patient from US (weight:NA) was diagnosed with the following health condition(s): pain and used Ultram (dosage: Twice A Day) starting 2010. Soon after starting Ultram the patient began experiencing various side effects, including:
    • Joint Range Of Motion Decreased
    • Pain In Extremity
    • Insomnia
    • Treatment Noncompliance
    Drugs used concurrently:NA. Although Ultram demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as joint range of motion decreased, may still occur.

    Activities Of Daily Living Impaired, Myoclonus, Myositis, Dyskinesia, Paraesthesia, Hypoaesthesia, Myalgia
    This activities of daily living impaired problem was reported by a physician from US. A female patient (weight: NA) was diagnosed with the following medical condition(s): pain.On NS a consumer started treatment with Ultram (dosage: NA). The following drugs/medications were being taken at the same time:
    • Lyrica
    • Vitamin D2 (50000 Unit, 3 X 1 Week)
    • Lasix (One Tablet Daily As Needed With Swelling, Eat Orange Or Banana.)
    • Flexeril (1 Tablet Orally Bid Npm)
    When commencing Ultram, the patient experienced the following unwanted symptoms /side effects:
    • Activities Of Daily Living Impaired
    • Myoclonus
    • Myositis
    • Dyskinesia
    • Paraesthesia
    • Hypoaesthesia
    • Myalgia
    Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as activities of daily living impaired, may become evident only after a product is in use by the general population.

    Asthenia, Dehydration
    This is a Ultram side effect report of a 69-year-old male patient (weight: NA) from US. The patient developed the following symptoms/conditions: arthralgia,vasculitis,neuropathy peripheral,rheumatoid arthritis,osteoarthritis and was treated with Ultram (dosage: 1-2 Tablets As Needed, Twice A Day.??from 25-jul-2012 To 28-jul-2012) starting Jun 13, 2012. Concurrently used drugs: NA. Soon after that, the consumer experienced the following of symptoms:
    • Asthenia
    • Dehydration
    The patient was hospitalized. This opens a possibility that Ultram could cause asthenia and that some male patients may be more susceptible.

    Dizziness, Fatigue, Restlessness, Pruritus, Hypopnoea, Nausea, Paraesthesia, Rash, Pain
    A 38-year-old female patient (weight: NA) from US with the following symptoms: arthralgia started Ultram treatment (dosage: 1 Pill 4-6 Hours Po) on Dec 28, 2012. Soon after starting Ultram treatment, the consumer experienced several side effects, including:
    • Dizziness
    • Fatigue
    • Restlessness
    • Pruritus
    • Hypopnoea
    • Nausea
    • Paraesthesia
    • Rash
    • Pain
    . Concurrently used drugs: NA. This finding indicates that some patients can be more vulnerable to developing Ultram side effects, such as dizziness.

    Hepatotoxicity, Overdose
    This hepatotoxicity side effect was reported by a physician from US. A 47-year-old female patient (weight:NA) experienced the following symptoms/conditions: musculoskeletal pain.The patient was prescribed Ultram (dosage: NA), which was started on NS. Concurrently used drugs: NA..When starting to take Ultram the consumer reported symptoms, such as:
    • Hepatotoxicity
    • Overdose
    These side effects may potentially be related to Ultram.

    Urticaria, Insomnia, Dizziness, Syncope, Loss Of Consciousness, Amnesia, Hypotension, Heart Rate Decreased, Oxygen Saturation Decreased
    This is a report of a 51-year-old female patient (weight: NA) from US, suffering from the following symptoms/conditions: NA, who was treated with Ultram (dosage: NA, start time: NS), combined with: NA. and developed a serious reaction and side effect(s). The consumer presented with:
    • Urticaria
    • Insomnia
    • Dizziness
    • Syncope
    • Loss Of Consciousness
    • Amnesia
    • Hypotension
    • Heart Rate Decreased
    • Oxygen Saturation Decreased
    which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Ultram treatment in female patients, resulting in urticaria side effect. The patient was hospitalized.

    Headache, Product Substitution Issue
    This report suggests a potential Ultram Headache, Product Substitution Issue side effect(s) that can have serious consequences. A 37-year-old male patient (weight: NA) from US was diagnosed with the following symptoms/conditions: pain and used Ultram (dosage: 1, Q4hr, Po) starting Aug 30, 2007. Soon after starting Ultram the patient began experiencing various side effects, including:
    • Headache
    • Product Substitution Issue
    Drugs used concurrently: NA. Although Ultram demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as headache, may still occur.

    Neuralgia, Arthritis, Post Polio Syndrome, Trigeminal Neuralgia
    This Neuralgia, Arthritis, Post Polio Syndrome, Trigeminal Neuralgia problem was reported by a consumer or non-health professional from US. A 63-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On NS this consumer started treatment with Ultram (dosage: NA). The following drugs were being taken at the same time:
    • Flexeril
    • Elavil (3 Per Day)
    • Cymbalta (2 X Day)
    • Celebrex
    • Neurontin (600mg 3 Per Day)
    When commencing Ultram, the patient experienced the following unwanted symptoms/side effects:
    • Neuralgia
    • Arthritis
    • Post Polio Syndrome
    • Trigeminal Neuralgia
    Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as neuralgia, may become evident only after a product is in use by the general population.

    Dizziness, Convulsion
    This is a report of a 57-year-old female patient (weight: NA) from US. The patient developed the following symptoms/conditions: NA and was treated with Ultram (dosage: NA) starting NS. Concurrently used drugs: NA.Soon after that, the consumer experienced the following side effects:
    • Dizziness
    • Convulsion
    This opens a possibility that Ultram treatment could cause the above reactions, including dizziness, and some female subjects may be more susceptible.

    Throat Tightness, Dyspnoea
    A 54-year-old female patient (weight: NA) from US with the following symptoms/conditions: pain started Ultram treatment (dosage: NA) on NS. Soon after starting Ultram treatment, the subject experienced various side effects, including:
    • Throat Tightness
    • Dyspnoea
    Concurrently used drugs: NA. This finding indicates that some female patients could be more vulnerable to Ultram.

    1 of 33 



    Top 10 Ultram Side Effects for Women

    Women Side EffectsReports
    Convulsion 74
    Nausea 48
    Dizziness 45
    Overdose 42
    Vomiting 37
    Somnolence 29
    Unresponsive To Stimuli 28
    Hypotension 27
    Headache 25
    Pain 25

    Keep Track of Side Effects

    Note Your Observations

    It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

    Why Your Notes are Important

    Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


    Discuss Ultram Side Effects

    Did You Have a Ultram Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Ultram for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Ultram Safety Alerts, Active Ingredients, Usage Information

    NDC10237-800
    TypeHUMAN OTC DRUG
    Proprietary NameUltraMax Invisible Solid Antiperspirant Deodorant Powder Fresh
    NameAluminum Zirconium Tetrachlorohydrex Gly
    Dosage FormSTICK
    RouteTOPICAL
    On market since20030619
    LabelerChurch & Dwight Co., Inc.
    Active Ingredient(s)ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY
    Strength(s)19
    Unit(s)g/100g
    Pharma Class

    Ultram Dosage, Warnings, Usage.

    Side Effects reported to FDA: 808

    Ultram safety alerts: 2012 2010

    Reported deaths: 56

    Reported hospitalizations: 277

    Gris-PEG (griseofulvin ultramicrosize): Health Advisory - Risk of Product Mix-Up

     

    [Posted 02/03/2012]

    AUDIENCE: Consumer

    ISSUE: Pedinol Pharmacal Inc. notified healthcare professionals, pharmacists and patients of a potential problem with Gris-PEG (griseofulvin ultramicrosize) 125mg and 250mg manufactured and packaged by Novartis Consumer Health at its Lincoln, Nebraska manufacturing site. Due to problems that occurred when these products were packaged and labeled at the site, tablets from one product type may have carried over into packaging of another product. This could result in a stray pill of one medicine ending up in the bottle of another product.

    BACKGROUND: Gris-PEG (griseofulvin ultramicrosize) is indicated for the treatment of ringworm infections.

    RECOMMENDATION:  Healthcare professionals, pharmacists and patients are advised to examine Gris-PEG tablets in their possession and ensure that all tablets are the same. For medications already in homes and pharmacies, there are simple steps provided at www.pedinol.com disclaimer icon and www.grispeg.com disclaimer icon to identify affected products.


    [01/24/2012 - Dear Healthcare Professional Letter - Pediniol Pharmacal]

    Related Medwatch Alert:

    [01/09/2012] Novartis Consumer Health Over-The-Counter Products Recall

    Latest Ultram clinical trials